Anti-arthritic effects of the novel dipeptidyl peptidase IV inhibitors TMC-2A and TSL-225

Immunopharmacology

Volumn 40, Issue 1, 1998, Pages 21-26

  Tanaka, Sumiko ^a   Murakami, Takanori ^a   Nonaka, Nobuaki ^a   Ohnuki, Tetsuo ^a   Yamada, Masaki ^a   Sugita, Takahisa ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Arthritis; CD26; Dipeptidyl peptidase IV; Protease inhibitor; TMC 2A; TSL 225

Indexed keywords

PROTEINASE INHIBITOR; TMC 2A; TRYPTOPHYL 1,2,3,4 TETRAHYDROISOQUINOLINE 3 CARBOXYLIC ACID; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD26; ARTHRITIS, EXPERIMENTAL; ASPERGILLUS; DIAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INDOLES; ISOQUINOLINES; KIDNEY; RATS; RATS, INBRED F344; SERINE PROTEINASE INHIBITORS; TETRAHYDROISOQUINOLINES;

EID: 0031665138     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(98)00014-9     Document Type: Article

References (16)

1. Buhling F., Kunz D., Reinhold D., Ulmer A.J., Ernst M., Flad H.D., Ansorge S. Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells. Nat. Immun. 13:1994;270-279.
2. Buhling F., Junker U., Reinhold D., Neubert K., Jager L., Ansorge S. Functional role of CD26 on human B lymphocytes. Immunol. Lett. 45:1995;47-51.
3. Dang N.H., Torimoto Y., Deusch K., Schlossman S.F., Morimoto C. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J. Immunol. 144:1990;4092-4100.
4. Dang N.H., Torimoto Y., Schlossman S.F., Morimoto C. Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family. J. Exp. Med. 172:1990;649-652.
5. Gonzalez-Gronow M., Gawdi G., Pizzo S.V. Characterization of the plasminogen receptors of normal and rheumatoid arthritis human synovial fibroblasts. J. Biol. Chem. 269:1994;4360-4366.
6. Hopsu-Havu VK G.G. A new dipeptide naphtylamidease hydrolysing glycyl-prolyl-beta-naphthylamide. Histmchemie. 7:1966;197-201.
7. Masuyama J., Berman J.S., Cruikshank W.W., Morimoto C., Center D.M. Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J. Immunol. 148:1992;1367-1374.
8. Muscat C., Bertotto A., Agea E., Bistoni O., Ercolani R., Tognellini R., Spinozzi F., Cesarotti M., Gerli R. Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients. Clin. Exp. Immunol. 98:1994;252-256.
9. Nonaka N., Asai Y., Nishio M., Takahashi K., Okuda T., Tanaka S., Sugita T., Ohnuki T., Komatsubara S. TMC-2A, -2B and -2C, novel dipeptidyl peptidase IV inhibitors produced by Aspergillus oryzae A374: I. Taxonomy of producing strain, fermentation, and biochemical properties. J. Antibiot. (Tokyo). 50:1997;646-652.
10. Oravecz T., Pall M., Roderiquez G., Gorrell M.D., Ditto M., Nguyen N.Y., Boykins R., Unsworth E., Norcross M.A. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186:1997;1865-1872.
11. Reinhold D., Bank U., Buhling F., Kahne T., Kunt D., Faust J., Neubert K., Ansorge S. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. Immunobiology. 192:1994;121-136.
12. Schon E., Born I., Demuth H.U., Faust J., Neubert K., Steinmetzer T., Barth A., Ansorge S. Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes. Biol. Chem. Hoppe-Seyler. 372:1991;305-311.
13. Shipp M.A., Look A.T. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key. Blood. 82:1993;1052-1070.
14. Tanaka S., Murakami T., Horikawa H., Sugiura M., Kawashima K., Sugita T. Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV. Int. J. Immunopharmacol. 19:1997;15-24.
15. Ulmer A.J., Mattern T., Feller A.C., Heymann E., Flad H.D. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7. Scand. J. Immunol. 31:1990;429-435.
16. Yi-Han Chang C.M.P., Chiyuki Abe Adjuvant polyarthritis IV. Induction by synthetic adjuvant: immunologic, histopathologic, and other studies. Arthritis Rheum. 23:1980;62-71.